MedTrace Logo

Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma

NCT00002492 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2016-12-15

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of combining cisplatin and doxorubicin in treating patients who have soft tissue sarcoma.

Conditions

  • Sarcoma

Interventions

DRUG

cisplatin

DRUG

doxorubicin hydrochloride

DRUG

isolated limb perfusion

PROCEDURE

conventional surgery

RADIATION

brachytherapy

RADIATION

radiation therapy

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Pasquale W. Benedetto, MD · University of Miami Sylvester Comprehensive Cancer Center

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1991-11-30
Primary Completion
2000-02-29
Completion
2000-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002492 on ClinicalTrials.gov